Article Information
History
- September 3, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Santos C Sieiro1,*,
- Fernández X Casas2,
- Morales C Moriano1,
- Alvarez E Diez1,
- Álvarez C Castro1,
- López A Robles1 and
- Sandoval T Perez1
- 1Rheumatology Department, Complejo Asistencial Universitario de León (León, Spain)
- 2Pharmacy Department, Complejo Asistencial Universitario de León (León, Spain)
- ↵*Corresponding authors: Sieiro Santos C. cristysieirosantos{at}gmail.com
Posted September 03, 2020.
Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe?
